Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Brook Campbell-Crawford
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters; questions recorded in 6).
- Questions
- 6on tracked calls
- Challenge rate
- 33%2 of 6 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 6with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 6 of 6 questions from 1 company
AMCRAmcor6 questions · 6 reporting periods · 2 of 6 challenging
Calendar 2026 Q2
I think there might have been some sort of benefit in the June quarter, perhaps given sort of accruals and things for incentive comp
Show response
Steve explained the modest year-over-year increase reflects a return to accruing at target compensation versus roughly 50% (below target) last year, when growth and cash flow fell short of original expectations.
Calendar 2025 Q4
can you provide some EBIT numbers in terms of what we should expect improvement in the non-core EBIT contribution in the second half versus the first half
Show response
Steve quantified: H1 non-core EBIT margins ~5% on ~$1.2B revenue. Q2 was worst at 3%. H2 expected to improve to 7-8% range on renegotiated contracts and better pricing, yielding ~$50M improvement. PK noted possible Q2 destocking in non-core that may reverse.
Calendar 2025 Q3
does EPS range you've given for FY '26 cover a scenario where volumes continue to decline at that sort of 2.5% year-over-year trend
Show response
PK expressed belief volumes could turn positive in H2 on softer comps and growth wins gaining traction. But even without macro improvement, guidance range is covered through cost flexing and synergy delivery. Recipe from Q1 would be repeated.
Calendar 2025 Q2
just how should we think about that for FY '26, I guess, accretion from the deal before synergies
Show response
Michael confirmed Berry Q4 accretion was ~$0.005-$0.01. Full year adjusted EPS of $0.712 is essentially the combined starting base. Berry net income was off about 4-5% vs prior year, a good proxy for Berry standalone performance. 12-17% FY2026 growth driven primarily by synergy delivery.
Calendar 2025 Q1
is there any sort of structural issues going on in that business that need to be discussed at this point?
Show response
PK emphasized volume decline aligns with market data, not share loss. Not yet ready to call it structural. Michael noted prior year included $5M Bericap EBIT and higher labor build for seasonally strong Q4.
Calendar 2024 Q3
the business has always talked about low single-digit topline growth organically. What's the new target for this
Show response
PK declined to give a specific new target but said growth can be better than pre-COVID expectations. Noted current volumes haven't fully recovered to pre-COVID levels with capacity utilization varying by category.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| AMCR Amcor | 6 | 33%2 of 6 questions |
- AMCRAmcor · 6 questions33%2 of 6 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 1 | 0%none of 1 question | 1 |
| 2024 Q4 | No questions recorded | — | — |
| 2025 Q1 | 1 | 100%1 of 1 question | 1 |
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 1 | 100%1 of 1 question | 1 |
| 2025 Q4 | 1 | 0%none of 1 question | 1 |
| 2026 Q1 | No questions recorded | — | — |
| 2026 Q2 | 1 | 0%none of 1 question | 1 |
- 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2024 Q4No questions recorded
- 2025 Q11 question · challenge rate 100% (1 of 1 question) · 1 company
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q31 question · challenge rate 100% (1 of 1 question) · 1 company
- 2025 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q1No questions recorded
- 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Margin2
- Guidance Reliability2
- Demand2
- Competitive Dynamics2
- Cost Pressure1
- Capital Allocation1
- M&A1
- Revenue Growth1